Structures by: Adjou A.
Total: 6
3-(1H-Benzimidazol-2-ylsulfanyl)propan-1-ol
C10H12N2O1S1
Acta Crystallographica Section E (2007) 63, 11 o4463-o4463
a=7.1472(3)Å b=11.5574(6)Å c=12.5284(6)Å
α=90° β=98.343(4)° γ=90°
(<i>E</i>)-Ethyl 2-cyano-3-[5-nitro-2-(pyrrolidin-1-yl)phenyl]acrylate
C16H17N3O4
Acta Crystallographica Section E (2010) 66, 10 o2497
a=8.4137(3)Å b=9.9517(4)Å c=10.3731(5)Å
α=73.0650(10)° β=71.388(2)° γ=72.523(4)°
5-Nitro-2-(piperidin-1-yl)benzaldehyde
C12H14N2O3
Acta Crystallographica Section E (2009) 65, 11 o2880
a=5.686(2)Å b=10.102(5)Å c=10.221(4)Å
α=80.767(2)° β=80.733(3)° γ=86.034(2)°
2-[2-(4-Methoxyphenyl)-2,3-dihydro-1<i>H</i>-1,5-benzodiazepin-4-yl]phenol
C22H20N2O2
Acta Crystallographica Section E (2010) 66, 1 o87-o88
a=27.5064(5)Å b=7.3811(2)Å c=19.5038(4)Å
α=90° β=117.699(2)° γ=90°
Ethyl 5-cyano-8-nitro-2,3,4,4a,5,6-hexahydro- 1<i>H-</i>pyrido[1,2-<i>a</i>]quinoline-5-carboxylate
C17H19N3O4
Acta Crystallographica Section E (2010) 66, 7 o1735
a=8.8257(4)Å b=9.2256(5)Å c=10.5011(6)Å
α=88.246(4)° β=75.089(2)° γ=83.289(3)°
Ethyl 4-cyano-7-nitro-1,2,3,3a,4,5-hexahydropyrrolo[1,2-<i>a</i>]quinoline-4- carboxylate
C16H17N3O4
Acta Crystallographica Section E (2012) 68, 2 o550-o551
a=7.2292(2)Å b=9.1589(3)Å c=11.8243(5)Å
α=79.3320(10)° β=82.6090(10)° γ=80.429(2)°